Privacy Analytics, Inc. announced the availability of a new solution designed to enable pharmaceutical companies to share clinical trials data while protecting the privacy of the individual patients.
Privacy Analytics, Inc. announced the availability of a new solution designed to enable pharmaceutical companies to share clinical trials data while protecting the privacy of the individual patients. Privacy Analytics' Open Clinical Trials Data Review, which runs on the company's automated risk-assessment, data request, PARAT software, compares existing industry anonymization approaches and finds privacy gaps.
The new offering accelerates the ability of pharmaceutical companies to meet increasing requests for individual-level participant data and clinical study reports by academicinstitutions, patients and other third-parties.
For privacy, regulatory and medical affairs executives, Privacy Analytics now provides:
Read the full release here.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.